Evidence based venous thromboprophylaxis in patients undergoing total hip replacement (THR), total knee replacement (TKR) and hip fracture surgery (HFS)

被引:1
|
作者
Autar, Ricky [1 ]
机构
[1] De Montfort Univ, Fac Hlth & Life Sci, Charles Frears Campus,266 London Rd, Leicester LE2 1RQ, Leics, England
关键词
Venous thromboembolism; Venous thromboprophylaxis; Deep vein thrombosis; Pulmonary embolism; Total hip replacement; Total knee replacement; Hip fracture surgery; Mechanical prophylaxis; Pharmacological prophylaxis; Venous thromboprophylaxis guidelines;
D O I
10.1016/j.ijotn.2011.01.001
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Patients undergoing total hip, knee replacement and hip fracture surgery are at high risk of developing venous thromboembolism. Incidence of deep vein thrombosis ranges from 40% to 70% and 1% to 7% for fatal pulmonary embolism. Venous thromboprophylaxis comprises mechanical and pharmacological intervention but for added protection in major orthopaedic surgery, most national and international guidelines advise a combined regimen of both modalities. Reportedly, 40% of such patients do not receive pharmacological prophylaxis because of the increased risk of bleeding. When considering pharmacological prophylaxis, a trade off between the benefits of reducing venous thromboembolism and the potential harms of bleeding and haematoma formation must be balanced. Anti-embolism stockings, intermittent pneumatic pump and foot impulse devices are the main mechanical methods but are often collectively addressed as mechanical prophylaxis as no difference in efficacy exists between these devices. The National Institute for Health and Clinical Excellence advises that one of those devices be commenced preoperatively and continued until the patients have no significant reduced immobility. Anti-embolism stockings (knee or thigh) are to be applied with caution. Mechanical prophylaxis is particularly important in hip/knee and hip fracture surgery, when patients are not protected by pharmacological prophylaxis. Unfractionated heparin, low molecular weight heparin, pentasaccharide fondaparinux and old and new oral anticoagulants are the mainstay of pharmacological prophylaxis. In the absence of contraindication, it is recommended that pharma-cological prophylaxis is timely initiated postoperatively. Extended pharmacological prophylaxis is recommended for 28-35 days for hip replacement and hip fracture surgery and 10-14 days for knee replacement surgery. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:145 / 154
页数:10
相关论文
共 50 条
  • [31] A Comparison of the Incidence of Acute Kidney Injury (AKI) Following Elective Total Hip Replacement (THR) and Total Knee Replacement (TKR) in Patients on an Enhanced Recovery Programme (ERP)
    Finlay, Emma
    Eitel, Cathryn
    Margarson, Michael P.
    Ayres, Bessie
    Akehurst, Harold
    Macallan, Jennifer
    ANESTHESIA AND ANALGESIA, 2017, 124 : 955 - 957
  • [32] Total knee and hip replacement for patients with hemophilia
    Zorenko, V. J.
    Karpov, E. E.
    Polyanskaya, T. J.
    HAEMOPHILIA, 2008, 14 : 81 - 81
  • [33] Opportunities for improvement: anticoagulation in patients undergoing total knee or hip replacement
    Thorsberger, Mads
    Jensen, Thomas
    Olesen, Jonas
    Weeke, Peter
    Wahlsten, Liv
    Jensen, Per
    Gislason, Gunnar
    Torp-Pedersen, Christian
    Koeber, Lars
    Fosbol, Emil
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2015, 20 (06) : 1036 - 1045
  • [34] Development of quality of care indicators for patients undergoing total hip or total knee replacement
    SooHoo, N. F.
    Lieberman, J. R.
    Farng, E.
    Park, S.
    Jain, S.
    Ko, C. Y.
    BMJ QUALITY & SAFETY, 2011, 20 (02) : 153 - 157
  • [35] Personality, function and satisfaction in patients undergoing total hip or knee replacement
    Ramaesh, Rishikesan
    Jenkins, Paul
    Lane, Judith V.
    Knight, Sara
    Macdonald, Deborah
    Howie, Colin
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2014, 19 (02) : 275 - 281
  • [36] Thromboprophylaxis and death after total hip replacement
    Amstutz, HC
    Dorey, F
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1997, 79B (06): : 1037 - 1038
  • [37] Thromboprophylaxis and death after total hip replacement
    Warwick, D
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1998, 80B (02): : 370 - 371
  • [38] Economics of thromboprophylaxis after total hip replacement
    Harrison, J
    Warwick, D
    Coast, J
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1998 - P1998
  • [39] Thromboprophylaxis and death after total hip replacement
    Ranstam, J
    Swierstra, BA
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1997, 79B (05): : 880 - 880
  • [40] Thromboprophylaxis and death after total hip replacement
    Murray, DW
    Britton, AR
    Bulstrode, CJK
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1996, 78B (06): : 863 - 870